NCT04906577

Brief Summary

At birth, the study of interactions, particularly sensory interactions between a mother and her child, allows us to better understand the process of attachment. The sensory signals within the mother-infant dyad will lead to behavioural and metabolic adaptations in both individuals. Currently, the conditions of reception of a very premature newborn in the neonatal intensive care unit of the CHU of Nice lead to a separation between mother and child, with a reduction in sensory interactions. The immediate and long-term consequences of this "sensory rupture" are widely documented in the child, but little studied in the mother. The hypothesis at the origin of this work is that olfactory stimulations emanating from the newborn would allow a perceptive continuity between the newborn and his mother. In the pathological situation of the birth of a premature child, these stimulations would lead to neurobiological and behavioural modifications in the mother and would play a role in the attachment process.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 28, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

September 12, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2022

Completed
Last Updated

February 7, 2024

Status Verified

February 1, 2024

Enrollment Period

1 year

First QC Date

May 25, 2021

Last Update Submit

February 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in ocytocine levels

    Day 4

Study Arms (2)

VIZOLF

EXPERIMENTAL

visual stimulus (photograph of the child) and olfactory stimulus ad libitum, with a minimum of 6 stimulations per day, to the body odour emitted by the child during the first 5 days of life

Other: photography+odour

VIZ

EXPERIMENTAL

visual stimulus (photograph of the child) and olfactory stimulus ad libitum, with a minimum of 6 stimulations per day, to a neutral odour during the first 5 days of life

Other: photography

Interventions

Daily from D0 to D5: a square of cotton cloth will be placed against the child's scalp by the childcare worker in charge of the child, then removed and placed in a sealed box containing a photograph of the child, which will then be given to the mother.

VIZOLF

A neutral smelling cloth will be placed with the child's photograph which will then be given to the mother.

VIZ

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Immediate postpartum mothers of newborns with a term of \< 33 weeks (32 weeks + 6 days)
  • primiparous mothers
  • Mothers with vaginal delivery, without oxytocin infusion after delivery
  • Mothers planning to breastfeed, with no maternal contraindication to breastfeeding

You may not qualify if:

  • Substance abuse: active smoking at the time of delivery, alcohol, drugs
  • Use of medication: antidepressants or psychotropic drugs or centrally acting anti-emetics
  • Active depression or history of depression (under medical care with medical follow-up) in the year preceding the birth, on questioning
  • Chromosomal abnormality or congenital malformation of pre- or post-natal diagnosis in the newborn
  • Language barrier not allowing proper explanation of the protocol and responses to questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nice

Nice, France

Location

MeSH Terms

Conditions

Premature Birth

Interventions

Photography

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

  • Florence CASAGRANDE, Dr

    Centre Hospitalier Universitaire de Nice

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2021

First Posted

May 28, 2021

Study Start

September 12, 2021

Primary Completion

September 15, 2022

Study Completion

September 15, 2022

Last Updated

February 7, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations